ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000243.1|Macrotetrolide_1 # 1 # 228 # -1 # ID=1_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.711	BGC0000243.1|Macrotetrolide_1 	1	228	-	Loose	890	26.1794	OprA	43.75	3003039	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCACACCGACACCGAGCGCTGCGTGCGAGCCGTCCAGTCCAAGGACGCCCGGTTCGACGGCTGGTTCTTCACCGCGGTCCTCACCACCCGGATCTACTGCCGCCCCAGCTGCCCCGTCGTACCGCCCAAGGTCCGCAACATGACCTTCTACCCGAGCGCCGCCGCCTGCCAGCAGGCCGGATTCCGGGCCTGCAAGCGGTGCCGCCCCGACACCAGCCCCGGATCC	MHTDTERCVRAVQSKDARFDGWFFTAVLTTRIYCRPSCPVVPPKVRNMTFYPSAAACQQAGFRACKRCRPDTSPGS	MPLSKLSASSLALCLGLLGACSLAPRYQRPEAPIPTTYPAVPASQQAGDRARLDDWQQQFTDPVLRQMIGQALEHNRNLRVAALRIEEARALYGVQASERLPTLEASGRYERERMRGETREAGEVEQRYRVAAGISAFELDFFGRVKNLGDAALADYLASEEAQRSARIALIAEVAGGYVQERALYAQQRLAERTLHARENGLALVRKRYAAGMSTRIDLRSEEMLVESARATHAALVRERSQAVSGLQLLLGDFTGDWQDSQLDLEHLQLQPLPAGLPSELLARRPDIRQAEQQLRAANANIGAARAAFFPSLRLSTDLGSASSGLHGLFRGGSRVWTFSPQMTLPIFDGGRNRANLDLAEVRKDIAVNRYEESIQVAFREVADALSAGDQLELQLRAQRAVRDADRERLQLVRKRYAKGVANYLEMLDAQRSLFDSEQQLIHLRGLRLNNGVALYRALGGGWSQG	16.27	gnl|BL_ORD_ID|1503|hsp_num:0	1570			78	153	erythromycin; amikacin; gentamicin C; ciprofloxacin; tetracycline; tobramycin; meropenem; arbekacin; norfloxacin; ofloxacin; gentamicin
BGC0000243.1|Macrotetrolide_2 # 339 # 872 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.712	BGC0000243.1|Macrotetrolide_2 	339	872	-	Loose	275	29.6462	Streptomyces rimosus otr(A)	31.43	3002891	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAGCACCTCTGTCTCCCCCGTCGTACGGCTGGTCCGCGGCGACATCACCGACCAGTCCGTCGACGTCATCGTCAACGCGGCGAACTCCTCGCTGCTCGGCGGCGGCGGAGTCGACGGCGCCATCCACCGGCGCGGCGGACCCGACATCCTCGCCGCCTGCCGTGAACTGCGCGCCTCGCGCTACGGAAAGGGACTGCCCACCGGGCAGGCCGTCGCCACCACCGCGGGGCGCCTCGACGCCCGGTGGATCGTGCACACGGTCGGCCCGGTCTTCTCCGGCGCCCAGGACCGCTCCGCCCTGCTCGCCTCCTGCTACCGCGAATCCCTGCGCCTGGCAGCGGAGTTGGGTGCCAGGTCCATCGCGTTCCCGGCGATCTCCACCGGCATCTACGGCTGGCCGATGGACGACGGTGCCCGGATCGCCGTACGCACGGTCCTGGCGGAGACCGTGGAGCCGGTCGAAGAGGTGCGCTTCGTGCTCTTCGACGCCCACGCGTACGTGGAGTTCGAGGAAGTCCTCGCGATGCGCTGA	MSTSVSPVVRLVRGDITDQSVDVIVNAANSSLLGGGGVDGAIHRRGGPDILAACRELRASRYGKGLPTGQAVATTAGRLDARWIVHTVGPVFSGAQDRSALLASCYRESLRLAAELGARSIAFPAISTGIYGWPMDDGARIAVRTVLAETVEPVEEVRFVLFDAHAYVEFEEVLAMR	MNKLNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAVATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLGIPTLVFVNKIDRGGARPDGVLREIRDRLTPAAVALSAVADAGTPRARAIALGPDTDPDFAVRVGELLADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHLVHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTGRVTEHAGRITALRVFEHGSATSETRATAGDIAQAWGLKDVRVGDRAGHLDGPPPRNFFAPPSLETVIRPERPEEAGRLHAALRMLDEQDPSIDLRQDEENAAGAVVRLYGEVQKEILGSTLAESFGVRVRFDPTRTVCIEKPVGTGEALIELDTRTHNYFWGAPWVCASDRPSPARAITFRLAVELGSLPLAFHKAIEETVHTTLRHGLYGWQVTDCAVTLTRTGVRSPVSAADDFRKANARLVLMDALGRAGTEVHEPVSSFELEVPAARLSPVLAKLAELGATPGVPTAEGDVFRLEGTMPTSLVHDFNQRVPGLTQGEGVFLAEHRGYRPAVGQPPVRPRPEGPNPLNRDEYILHVLKRV	26.70	gnl|BL_ORD_ID|4807|hsp_num:0	1273			1434	1644	oxytetracycline
BGC0000243.1|Macrotetrolide_3 # 918 # 2324 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.750	BGC0000243.1|Macrotetrolide_3 	918	2324	-	Loose	1000	33.8834	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide	30.85	3005106	protein variant model	W69C	W69C:3836	thioamide antibiotic	antibiotic target alteration	prothionamide resistant ethA	ATGCTCGATGCGGTCGTGGTGGGCGCGGGGCCCAACGGACTGACCGCCGCAGTCGAACTGGCCCGCCGGGGCTGCTCGGTGGAGGTCCACGAGGCGCACGACACCATCGGCGGGGGAGCTCGCACCGAGGAGCTGACCCTCCCGGGGTTCCGGCACGACCCCTGTTCCGCCGTGCACCCCCTCGCGATCGGCTCGCCCGCGTTCCGGGGCATGCCGCTGGACCGCCACGGCCTCCAGTGGCTGCACCCCGAGATCGACCTCGCGCACCCCTTCCCGGACGGCACCGCCGCCACGCTCACCCGCTCGGTGGGGGAGAGCGCGATGTCACTGGGGGCCGCCGACGCCGGGGCCTACCGCCGCCTGATGGCCCCCTTCGTCGGCCGCTGGGACACCCTGGCCGCCGACTTCCTGCGCACCCCCTGGGACGGCCTGCCCCGCGACCCCTACCGGCTGGCCCGCTTCGGTCTGCTCGGCCTCCAGCCCGCCACCTGGCTCTCCCGCCGCTTCTCCGGTGAGAAGGCCCCCGGCCTCTTCGCCGGGCTCGCCGCCCACGCCATAGCTCCCACCAGCGGATTCGCCACCGCGGCCATCGCCCTCGTCTTCGCGCTCGCCGCCCACGAGAACGGCTGGCCGGTGCCGCGCGGCGGCTCCCAGTCCATCTCGGACGCCCTCGCCTCCTACCTCCGCGAACAGGGCGGCACGATCCGCACCGGCAGCGAGGTCAAGCGCCTGGACGATCTCCCGCCCGCCCGCGCCTACATCTTCGACACCTCGCCCTCCGCCCTGGCCCGGATCGCGGGCCTCGGCTCCGCGTACCACCGCTACCGCTACGGCGCCTCCGCCTTCAAGATCGACTACGCGCTGTCGGGCCCCGTCCCCTGGACCGCGCCCCAGGCCCGCCGCGCGGGCACCGTCCACATCGGCCCCGACGCCGGAACGATCGACGCCGCACTGACGGCGGCCGTCGCGGGCCGCGACCCCGACGTCCCCTTCCTCATCACCGCGCAGCCCAGCGTGATCGACCCCTCCCGGGCCCCCGAAGGACGCCATGTCTTCTGGGCGTACGGGCACGTGCCGGCGGGCTGGGAGGGCGACGCCACCGACGTCATCGAACGCCAACTGGAGCGTTTCGCCCCCGGGTTCCGCGATCTCGTGCTCGCCCGCGCCCTCGCGGGCCCGCCCCAACTCGCCGCGCGCAACGCCAATTACGTCGGCGGCGACATCGCGTGCGGGGCTTTCGCCGGTCTCCAGACGCTGATCCGCCCCAAGCTCGCCCGCGTCCCCTACGCCACCGCGCACCCCGCGGTCTTCCTCTGCTCCTCGGCCACCCCGCCCGGACCCGGGGTCCACGGCATGTCCGGCCACCACGCCGCCAAGGCCGTATGGCGAAGGCTGCGGGCCTCCTGA	MLDAVVVGAGPNGLTAAVELARRGCSVEVHEAHDTIGGGARTEELTLPGFRHDPCSAVHPLAIGSPAFRGMPLDRHGLQWLHPEIDLAHPFPDGTAATLTRSVGESAMSLGAADAGAYRRLMAPFVGRWDTLAADFLRTPWDGLPRDPYRLARFGLLGLQPATWLSRRFSGEKAPGLFAGLAAHAIAPTSGFATAAIALVFALAAHENGWPVPRGGSQSISDALASYLREQGGTIRTGSEVKRLDDLPPARAYIFDTSPSALARIAGLGSAYHRYRYGASAFKIDYALSGPVPWTAPQARRAGTVHIGPDAGTIDAALTAAVAGRDPDVPFLITAQPSVIDPSRAPEGRHVFWAYGHVPAGWEGDATDVIERQLERFAPGFRDLVLARALAGPPQLAARNANYVGGDIACGAFAGLQTLIRPKLARVPYATAHPAVFLCSSATPPGPGVHGMSGHHAAKAVWRRLRAS	MTEHLDVVIVGAGISGVSAAWHLQDRCPTKSYAILEKRESMGGTWDLFRYPGIRSDSDMYTLGFRFRPWTGRQAIADGKPILEYVKSTAAMYGIDRHIRFHHKVISADWSTAENRWTVHIQSHGTLSALTCEFLFLCSGYYNYDEGYSPRFAGSEDFVGPIIHPQHWPEDLDYDAKNIVVIGSGATAVTLVPALADSGAKHVTMLQRSPTYIVSQPDRDGIAEKLNRWLPETMAYTAVRWKNVLRQAAVYSACQKWPRRMRKMFLSLIQRQLPEGYDVRKHFGPHYNPWDQRLCLVPNGDLFRAIRHGKVEVVTDTIERFTATGIRLNSGRELPADIIITATGLNLQLFGGATATIDGQQVDITTTMAYKGMMLSGIPNMAYTVGYTNASWTLKADLVSEFVCRLLNYMDDNGFDTVVVERPGSDVEERPFMEFTPGYVLRSLDELPKQGSRTPWRLNQNYLRDIRLIRRGKIDDEGLRFAKRPAPVGV	95.71	gnl|BL_ORD_ID|2821|hsp_num:0	3837			12	291	prothionamide
BGC0000243.1|Macrotetrolide_4 # 2430 # 3275 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.748	BGC0000243.1|Macrotetrolide_4 	2430	3275	-	Loose	500	27.7202	OXA-57	24.05	3001771	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGATCGATGACTTCCTGTACGGGACCGCCGGGCACACCGGACCGCCGGCCGAGGTCGAGGCCGCCGTGCGCGCCGCCGCCGCGGCCGAGATCATGCCGCGCCATCGGAAGCTCGCCGCCCACGAGATCATCGAGAAGAGCGGCCCGCACGACCTGGTCACCGCCGCCGACCGGCTGGCCGAGGAGCACCTCACCGCCGCCCTCACGAAACTGCTGCCCGGCTCGGTCGTCGTCGGTGAGGAGTCCGTGCATGCCGACCCGGCGGTCTACGAGGCCCTCGACGGCGACGCCCCGGTCTGGATCGTCGACCCGGTCGACGGCACCCGCCAGTTCGTCCGGGGCGAGGCCGGCTTCTGCACCCTGGTCGCCCTCGCCCTCCACGGCGAGGTGCACGCCTCCTGGACGTACGCACCGGTCCGGGGCGAGATGGCCATAGCCGTACGCGGACGGGGCGCCACGCTCAACGGGGCGCCGATACGCTCCGGGGCGCCCGCACCCGGCGCCGTGCTGAAGGTGGCGATGTCGCACCCCGACTACACCACCGAGGCCCAGAAGCGGGCCCTGCTCGGCCTGCGCACCGAATCCATCGCGGCCCGCCCCTGCGGCTCGGCCGGACTCGAGTACCTCGCCGTCGCCCGCGGCTCCCTGGACGCCGTCGCCTTCAACTGGGAGTACGCCTGGGACCACGCCGCGGGCTTGCTCCTGGTCACCGAGGCGGGCGGCGCCCAGTCGACCCTGTCCGGCGCCCCGTTCCGCATCGCGGGCGGCAACGACCTGCCGTTCACGGCCGCCCGCGACGAGGCCACCGCCCAGCGCGTCCTGGCCGCCCTGCGCACGGGCGGCTGA	MIDDFLYGTAGHTGPPAEVEAAVRAAAAAEIMPRHRKLAAHEIIEKSGPHDLVTAADRLAEEHLTAALTKLLPGSVVVGEESVHADPAVYEALDGDAPVWIVDPVDGTRQFVRGEAGFCTLVALALHGEVHASWTYAPVRGEMAIAVRGRGATLNGAPIRSGAPAPGAVLKVAMSHPDYTTEAQKRALLGLRTESIAARPCGSAGLEYLAVARGSLDAVAFNWEYAWDHAAGLLLVTEAGGAQSTLSGAPFRIAGGNDLPFTAARDEATAQRVLAALRTGG	MKFRHALSSAFVLLGCIAASAHAKTICTAIADAGTGKLLVQDGDCGRRASPASTFKIAISLMGYDAGFLRNEHDPVLPYRDSYIAWGGEAWKQPTDPTRWLKYSVVWYSQQVAHHLGAQRFAQYAKAFGYGNADVSGDPGQNNGLDRAWIGSSLQISPLEQLEFLGKMLDRKLPVSPTAVDMTERIVESTTLADGTVVHGKTGVSYPLLADGTRDWARGSGWFVGWIVRGKQTLVFARLTQDERKQPVSAGIRTREAFLRDLPRLLAAR	104.46	gnl|BL_ORD_ID|1885|hsp_num:0	2048			381	789	cloxacillin; oxacillin; cefalotin
BGC0000243.1|Macrotetrolide_5 # 4061 # 4681 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.676	BGC0000243.1|Macrotetrolide_5 	4061	4681	+	Loose	500	27.7202	mphK	27.08	3004541	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGGCCGAGAAGGGCAGACGCGGACTGATGGTCCTGCACTCGTCACCTTTGATACGCAAGGCGATTCTCGATCTGTTCCGGGGCGATCCCGGCGTCACCGTACTGGGCGGCTGTCCGCACCCGACCGCTGTCGGCAGCCTCCCCGGACGCCGGCCCGACGTCGCGCTCGTGGAGTACGAGCAGTGGCAGGAGGTGCTCGGCAATCTGGCGTACTGGAGCGGCACCCGGGTCATCCTCTACAGCAGGGACAACACCCCCCGCAGCGTGGTGGATTGCATCAGGGGCCGGGCCGCCGGGTTCGTGCACGAGTCGTGCCCGCCCGAGTCCATCGTCAAGGGGCTGCACGATGTGCTGAGCGGGCGCGGCTTCTGGCACCTGGGGGCCGACGAGCCCGAGGGCGTACCGGTGACCCGGCACGCCGCAGCGGGCGGGAAGTGGAAACTGAGCGGACGCGAGGAGGAGATCCTCGGGCTCTTACTCCGCAGACGCTCGAACGAGGAGATCGCGGATGAGCTGTGCCTCACCCAGCAGACCGTCAAGAACTACGCGAGCCGGGTCTTCCACAAGGTGGGCGTGTCCGGACGCAAGGAGCTCTTCAGGATGCTGAGGCCCTGCGGATGA	MAEKGRRGLMVLHSSPLIRKAILDLFRGDPGVTVLGGCPHPTAVGSLPGRRPDVALVEYEQWQEVLGNLAYWSGTRVILYSRDNTPRSVVDCIRGRAAGFVHESCPPESIVKGLHDVLSGRGFWHLGADEPEGVPVTRHAAAGGKWKLSGREEEILGLLLRRRSNEEIADELCLTQQTVKNYASRVFHKVGVSGRKELFRMLRPCG	MTNLNEKQLITEIVGLARSQGLTVHSENAQLNETGMDFQVVFAKDDTGMPWVLRKPRRSDVVERASAEGITLAFLRANLTADVPDWRIHTPELIAYPMLKGTPAAGIDLEQKQYVWNMDHQPPSDDFVRTLADILAELHGTDQISAGQSGIEVIRPEDFRQMTADSMVDVKNKLGVSTTLWERWQKWVDDDAYWPGFSSLIHGDLHPPHILIDQNGRVTGLLDWTEAKVADPAKDFVLYQTIFGEKETARLLEYYDQAGGRIWAKMQEHISEMQAAYPVEIAKLALQTQQEEHINMALEALGVTSD	67.32	gnl|BL_ORD_ID|2624|hsp_num:0	3217			525	666	telithromycin; azithromycin
BGC0000243.1|Macrotetrolide_7 # 5489 # 5686 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.727	BGC0000243.1|Macrotetrolide_7 	5489	5686	+	Loose	600	23.0978	msr(G)	47.37	3007042	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic target protection	msr-type ABC-F protein	ATGGCAGGCGCTTCGTTGCAGCGGGTGAGCTGCGCCGTTAGGCTTGTTGATCCGGCGCTCCTGGAGGCGGGCGTCCGGCTGTTGCGGGACTCCGGGCACCTGGACCGCACGGCGGCGCTCGGCGTGGAGAACGGCTACTGGTGGCAGGCCGCGTCCGCCGCGAACCGGGACCCCTCGCCCTCCTCCGGACGACCCTAG	MAGASLQRVSCAVRLVDPALLEAGVRLLRDSGHLDRTAALGVENGYWWQAASAANRDPSPSSGRP	MEQICFELENVEVTYLDKEVLKIERLAVHQFDRIGIVGKNGAGKSTLLKLLAGIIKPTTGKVNRLVENGYFEQLETPSVRDADPVLLGKLDVPKDSNQLSGGEQTRMKLAKLFTHYYEALLIDEPTTHLDQEGISFLLDELRYYYGALVLISHDRSVLDELVTTIWEVHEGKVRIYSGNYSDYMAQKKLEREQQSQAHEQFIKEKSRLEKAAQEKMKKAEKVAQAGRLSKKDANAKPDKSFMTKSKGTSQKAMQRAAKAIEQRMEKLQEVDAVKEDRQINFHQSRNLELHNKFPIMADRFTLQVDNKVLLNEVSFQMPLGKKIAISGKNGAGKSTLLHHIAINAPGLTISPKAKIGYFRQMSYQYTRDETVLEFLKNRSEYDERFLRSVLHSMLFVGTDILKSVKSLSGGEAIRLQLCQLFLGEYNILLLDEPTNFLDIYAIEALERFITAYKGTIIFVSHDRRFIDCVADCIYFIEDQQLKLRG	13.40	gnl|BL_ORD_ID|4749|hsp_num:0	5743			195	252	erythromycin; azithromycin
BGC0000243.1|Macrotetrolide_8 # 5904 # 6860 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.711	BGC0000243.1|Macrotetrolide_8 	5904	6860	+	Loose	570	159.458	bcrA	32.13	3002987	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGACCCCTCTCATCGAATGTACCGACGTCACCAAGAAGTTCGGTGACTTCACCGCGCTGAGCCGGCTGAACCTGACCGTCCCCCAGGGCGTGGTCTACGGATATCTGGGCCCCAACGGAGCGGGCAAGAGCACCACGATCCGTATGCTCATGGGCCTCTCCCGGCCCACATCCGGCCAGGTCCGGGTGCTCGGCCAGGACCCGACCGACCCCGAGGTCCGGCGGCGCATCGGCTATCTGCCGGGTGAACTGCGCCTGGACGAGCGGCTGACCATCGGTCAGACGCTGGCCTCCTGGGGGCGGCTGCGAGGACTGACGGACACCGCCTACCGGGACGAGCTGGTCCAGCGGTTCGGCATCGACCCGTCCCGGCGGGTGCGCGGGCTCTCCACCGGCAACCGCCGCAAGGTCGGCCTGGTCGGCGCCTTCATGGCCAAGCCGGAGCTGCTGATCCTCGACGAACCGACCAACGGGCTCGACCCGTTGATGCAACAGGTGTTCCTCGCCACCGTCGAGGAGGCCCGGGACAACGGGCAGAGCGTGCTGCTCTCCTCGCACATCCTCTCCGAGGTCGAGCGGGTCGCCGACGTGGTCGCGGTGCTCCAGGGCGGCAGGCTCGCCGCCTCCGGTCCGACACAGGAACTGCGCCGCCGGGCCGCACAGCGTTTCCACATCACCTTCGCGGAGGGCGAGGACGTCCCGCTCGCCGCACTGGCCGGCCTGGAGGGCGCGTCGGACGTGGAGCGGCGCAGTCCGGAGGGCCAGGTGGTCTCCCTGGCCTGGGCCGGCTCGCCCGACGCACTGCTGAAGTTCCTGGCGGGCCGCCGGATCACGACGCTCACCGCGCCCGAACCGGACCTGGAGGAGGCGTTCCTGGAGTACTACCAGAGGGATGTCCCGGGCAGCCGCGACGCCGAGGCCGAAGAGCCCTCCGCGGCCGCAGGCCCGGTGCGGTAG	MTPLIECTDVTKKFGDFTALSRLNLTVPQGVVYGYLGPNGAGKSTTIRMLMGLSRPTSGQVRVLGQDPTDPEVRRRIGYLPGELRLDERLTIGQTLASWGRLRGLTDTAYRDELVQRFGIDPSRRVRGLSTGNRRKVGLVGAFMAKPELLILDEPTNGLDPLMQQVFLATVEEARDNGQSVLLSSHILSEVERVADVVAVLQGGRLAASGPTQELRRRAAQRFHITFAEGEDVPLAALAGLEGASDVERRSPEGQVVSLAWAGSPDALLKFLAGRRITTLTAPEPDLEEAFLEYYQRDVPGSRDAEAEEPSAAAGPVR	MSTIIKTTDLTKMYGSQKSVDHLNINVKQGDIYGFLGRNGAGKTTTIRMLLGLIKPTSGQIEIFGENFFKNKKEILRRIGSIVEVPGFYANLTARENLLINAKIIGIHKKNAIDEVLEIVGLQHETKKLVGKFSLGMKQRLGIARALLHYPELLILDEPTNGLDPIGIKEMRRLIHSLAKERNITIFISSHILSEIEQLVDHVGIIHEGKLLEEIPFDHLKKRNRKYLEFQLSDQNKAVVLMEQHFDIHDYEVHQDGIIRVYSHLGQQGKLNKLFVENGIDVLKITMSEDSLEDYFVKLIGGGTIG	103.92	gnl|BL_ORD_ID|315|hsp_num:0	345			0	894	bacitracin; bacitracin A; bacitracin B; bacitracin F
BGC0000243.1|Macrotetrolide_9 # 6934 # 7740 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.705	BGC0000243.1|Macrotetrolide_9 	6934	7740	+	Loose	700	25.7942	tet(A)	30.0	3000165	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCATCGCCCAGCTCGGAGATCTTCCGGCGCGGAGTACAGATCCAGAAGCGCACCCTGATCGCCTGGTCGGCCGCGCTGGTCCTGCTCGCACTCTCCGTCGTCGGCGCCTGGCCCTCGATGGAGGAGTCCGGCGCCCTGGAGGACTTCTCCTCCGGCATATCGCCGGAGATGGCCGCCGCCTTCGGAATCGACCAGATCAGCAGCGCGAGCGGCTACCTGAAGGGGAACCTGTACGCGGTACTGCTGCCGCTGCTCCTCGGCCTGATGGCCGTGACCGCGACCGCCGCCCTGACCGGCGGCGACGAGGAGGCCGGGCGGCTCGAACTGCTGCTCGCGCTGCCGGTCGCCCGCCGCACGGTCTTTCTGGTGCGCTTCCTCTGCGTGACCTTCGGCCTGGCCCTCACCAGCATCCTGGTCTGGCTGTCGGTGTACGGCTCGGTCGTCTCCTTCGACATGGACGTCTCCGGAGGCGGGGTCGCCGCCGTGACGCTGACCGTCGGTCTGCTGGCCGTGCTGCACGCGGGTGTCGCGTACGCCGTCGTCGGGTTCGGCTTCGGGCGCGGTCCCGCACTCGGCGTGGCGGCCGGTGTGCTCGTCGTCGGGTATCTGCTGCACGCCATCGCGCCGATGTCCGACTCCCTGGAACCGCTGGCGAACATCTCCCCGTGGGAGTGGGCGCTGGGCAGCGACCCGCTGCTCAACGGCGTTCCCTGGGGCGGGGTCGCGCTGCTGGTGGTCCTCTCGGCCGCGATCGTCGCCGCCGGTACGTACGCCGTGGACCGACGCGACGTCAAGAACGCCTGA	MSSPSSEIFRRGVQIQKRTLIAWSAALVLLALSVVGAWPSMEESGALEDFSSGISPEMAAAFGIDQISSASGYLKGNLYAVLLPLLLGLMAVTATAALTGGDEEAGRLELLLALPVARRTVFLVRFLCVTFGLALTSILVWLSVYGSVVSFDMDVSGGGVAAVTLTVGLLAVLHAGVAYAVVGFGFGRGPALGVAAGVLVVGYLLHAIAPMSDSLEPLANISPWEWALGSDPLLNGVPWGGVALLVVLSAAIVAAGTYAVDRRDVKNA	MSTNLSVIKNPRVQSDQRRLVRRPDVKPNRPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACAPVLGALSDRFGRRPVLLVSLAGAAVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYIADITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFLLPESHKGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRFHWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRGWMAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAASITTWNGWAWIAGAALYLLCLPALRRGLWRNSSNSRCT	63.21	gnl|BL_ORD_ID|1792|hsp_num:0	1808			288	528	tetracycline
BGC0000243.1|Macrotetrolide_11 # 9230 # 11005 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.741	BGC0000243.1|Macrotetrolide_11 	9230	11005	+	Loose	525	28.1054	DHT2-1	34.52	3006872	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	DHT2 beta-lactamase	ATGACCACAGCCCTCGAACGCCCCTCCACCACCGGCCCCTACCTGGCCACCGGCCCCGACGACCTGATACGCCGCTTCGTCCGCGAGGGCGACCACGTGCACGCCGCGGCGACGATGTCGCGGCCCAACGCCCTGCTGAACGCGGTGTGCCGGACCTTCGCCGGGAGCGGCAGCATGACGGTGAGCACCACCGCCGTGCACTCCAGCGCCCATGCGCTGGCCCTCTCCGGCGCCGTACGCAAGGTGATCACCGGGTTCGTCGGCGACACCTACCCCTCACCGCGCCCCAACCGCCTCTACCGCGAGCTGGCCGAGGGCCGGCCGTTCGAGGTGGAGATGTGGTCGCTGCTGAGCTACACGCAGCGGCTGATGGCCGCGGCGCTCGGCCAGCCCTTCGCCACCACCGGCTCGATGCTCGCCGAGACCGACCTCCGGCACGGCAAGGAGGGCAAGCTCCACCTGGTGCCGCACCCCGAGGACCCGGAGCGCACCGTCACCCTGCTCAGCCCGCTGCGCCCGCGCTTCACCCTCTTCCACGGTGTCGCCGCCGACCGCCGGGGCAACGTCGTGGCCTGCCCCCCGCTGGGCGAGGGCGCCTGGGCCGCGTACGCCGCCACCGAGGGGGTCCTCGCCTCCGTGGAGGCGATCGTCGACGACGAGGTGATCGCCGCGATGCCGGACCGGGTGGTGATCCCCGCCGCCCGCGTCCTCGGCCTGTGCGAGGCGCCGCTCGGCGCCCACCCGCAGTCACTGCGCACGGGTGGACTGGCCGGAGTCGACGGCTACCTGGACGACTACGACTTCCTCACCGACATCGTGGCCGCCTGCAAGGACCCGGAGTCCGCCGCCGCCTGGTACGAGAAGTGGGTCGGCGGGGCGGGCAGCCACGCCGACTACCTGGAGCGGCTGGGTGGGACCCGCCGCGCCGCGCTGGTGTTCCCCGCTCCCCCGGGCGTCCCGGTCGCCGTGGAGAAGGACCGGAGCCCGGCGGACGGGTCCGCCGCCCCCACCGAGCAGGAGCAGCTCATCGTGCTCGGCGCCCGCGCGATCGTCGACCTGGTCCGGGAGCGCGGCTACGACACGCTGCTCGCCGGGATCGGCACCTCGCACATGTCCGCGTGGCTGGCGGCCCGGCTGCTGGGACGCGACGGCGTCCAGGTGCAGGTGGCCGCCGAGCTGGGCCTCCAGTCGATGGACCCCGAACCCGGCGACGTCTTCCTCTTCAGCCAACGGCACGCCGAGCGCTCGCAGATGCTGGCGGGCGTCGCGGAGACGCTGGGCGGCGCGGTCGCCGCCAACCCGCGCTGCCTGGGCGTGCTCTCCGCCGCGGAGATCGACCCGGACGCCAACATCAACACGACGCTGCTGCCCGACGGCCGTTGGATCACCGGCTCCGGCGGGGCCAACGACATCGCCTCGTCCGTGGACTGCGTCGTGATCGCGGTCGCCTCGGCCCGCCGCTACGTACCCCGGCTGACCCACCTCACCAGTCCGGGCCTGCGGGTCCGCGACGTGGTCAGCCAGTTCGGGCGCTTCACCCGCGCCGGGGCCGGCGACGCCTTCGAGCTGGCGAGCTGGCTGCCGCCCGTTCCGGGCCGCGGCCGCGCCGGGAAGGACCTCCCCGACGGGCCGGAGGCGGCGGTGCGCGACCTCACCGGCTGGGAGTTCCCCGCGGCCTCCACCGGGGTCAGCGGCTTCCTGACCGACGAGAAGGCCGTCACCACCGAAGAACTCGTCCTCCTGCGCACCATGGACCCGGAAGGTTTCTACCGATGA	MTTALERPSTTGPYLATGPDDLIRRFVREGDHVHAAATMSRPNALLNAVCRTFAGSGSMTVSTTAVHSSAHALALSGAVRKVITGFVGDTYPSPRPNRLYRELAEGRPFEVEMWSLLSYTQRLMAAALGQPFATTGSMLAETDLRHGKEGKLHLVPHPEDPERTVTLLSPLRPRFTLFHGVAADRRGNVVACPPLGEGAWAAYAATEGVLASVEAIVDDEVIAAMPDRVVIPAARVLGLCEAPLGAHPQSLRTGGLAGVDGYLDDYDFLTDIVAACKDPESAAAWYEKWVGGAGSHADYLERLGGTRRAALVFPAPPGVPVAVEKDRSPADGSAAPTEQEQLIVLGARAIVDLVRERGYDTLLAGIGTSHMSAWLAARLLGRDGVQVQVAAELGLQSMDPEPGDVFLFSQRHAERSQMLAGVAETLGGAVAANPRCLGVLSAAEIDPDANINTTLLPDGRWITGSGGANDIASSVDCVVIAVASARRYVPRLTHLTSPGLRVRDVVSQFGRFTRAGAGDAFELASWLPPVPGRGRAGKDLPDGPEAAVRDLTGWEFPAASTGVSGFLTDEKAVTTEELVLLRTMDPEGFYR	MSSIVRGVRAAVVASAISLAAAFACLPLAAADATREPVLPQSGRYEVPDSWRQPIAPVRIADHTWYIGTENLSAVLVTTPQGAVLIDGGMPQAADMLLQRMRDVGIAPGDLRWILVSHAHADHAGPVAKVKRATGARIAANAESAAMLARGGTDDIHFGDDITFPPAQADRLLQDDEVVQVGGIALTGHVTPGHTPGSTSWTWTDTKDGKPVRIAYADSLSAPGYKLIGNPRMPRIVEMYEATFAKVRALPCDLLLTPHPDASGWTPADAANPHPSPKTCAAYADEMEAKFDAELAKQRAAK	195.70	gnl|BL_ORD_ID|3515|hsp_num:0	4584			198	447	
BGC0000243.1|Macrotetrolide_12 # 11002 # 12045 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.693	BGC0000243.1|Macrotetrolide_12 	11002	12045	+	Loose	500	27.335	Rhodobacter sphaeroides ampC beta-lactamase	26.67	3004291	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	ampC-type beta-lactamase	ATGACCACCACCGCCGACACCGTCCCCGACCCGGCGACGGCACATCTGCGCCCGCTGCCGCCCACCGCGATCGCCCCCGTGCGGCTCGCCGGGATCGGCCACTACTTCCCCGGCGAGCCGATCACCAACGCCCACTTCGAGCAGATCGAGGCGCTGGGCATCGACGACGCCTGGATCCGCGAGAACACCGGGATCGTCAGCCGCCACTGGCCGGCCGACGAGAAGGAACGCGCGGTGGAGATGGCGGCCAAGGCGGTGGACGACGCCCTGAACGCCGCCGGTCTGGGGCCCGACGACATCGATCTCGTCATCGGCACGACGTCCACCACCCGGCCGCGGGTCAACCCCTCCAGCGCCACCAACAACTACATGGACATCTCGCTGCCGCTCCAGAAGCAGGTCGGGCTGCGCCACGCCACCTGCTTCGACGTCACCTCGGTGGCCTGCGCCGGCTTCATGTACGGCACCGCGACGGCCGCCGCGATGCTTCCGGCGCTCGGCATGCGCAACGCGCTGGTCGTCTGCGCGGAGAACCCGCGCCCGATCCTGAACTTCGACTACCGCTACTCGGCGCTGTTCGGGGCGGGGGCCGCCGCGGCGGTCTGGTCGGCGGACACCGAGGAGCACGGGCTGCTGGACGTGGCGCTGCACGCGGACGGCTCGTACTTCGACGCCTTCGACATCGACGAGAACGACAAGATGCTGATGCGCGGCCGGGAGGTCGGCGCGGTCGGTCCGAAGCTGCTCTCCCACGTGGGCCTGGAGATCCTGGAGCGCAACGGCCTGACGGTGGACGACATCGACTGGTTCGTGCCGCACCAGGGCAACCTGAACATGATCAACCAGGTGTGCCGGACGCTGGAGATCCCGCGCGAGAAGCTCCTCACCAACATCCAGGAACGCGGCAACACCTCCAGCGTCTCCATCCCCAGCTGCCTCTCCGAGAACCTCGGTTCCGGGAAGATCCGCTCCGGCGATCTCGTCGCGACGATCGGCATCGGCCGCGGCTTCAGCTGGGGCGCGATGCTCCTGCGGATTCCGTGA	MTTTADTVPDPATAHLRPLPPTAIAPVRLAGIGHYFPGEPITNAHFEQIEALGIDDAWIRENTGIVSRHWPADEKERAVEMAAKAVDDALNAAGLGPDDIDLVIGTTSTTRPRVNPSSATNNYMDISLPLQKQVGLRHATCFDVTSVACAGFMYGTATAAAMLPALGMRNALVVCAENPRPILNFDYRYSALFGAGAAAAVWSADTEEHGLLDVALHADGSYFDAFDIDENDKMLMRGREVGAVGPKLLSHVGLEILERNGLTVDDIDWFVPHQGNLNMINQVCRTLEIPREKLLTNIQERGNTSSVSIPSCLSENLGSGKIRSGDLVATIGIGRGFSWGAMLLRIP	MKHLSPLSILLMVGALTPALAQDTTPSFESAAAAAFESVIEEHDIPGLVVGVTHGGRHSFYQTGLASREDQQPVTPDTLFELGSISKIFNVTLAALAEERGALSLDAPVADYLPSLRGSPAGELTLIDLATHHTGGLPLQVPDEVADVDRLVDWLRSWRPPEPGTRSYSNISIGLLGHITAGVLGMSYADASQTVIFPALGLKSTWIDVPTDAMGRYAFGYDRKTDAPTRVTPGVLDDEAYGVKSSARDMLTLLDLELGTGTASPEVQTAVATTQEGRFQTRLYTQAMIWEAYPWPVDPERLVEGNGYDFILQPQPVDEVDTTPDRRVILNKTGSTNGFGGYIAIVPSEDLGVVVLANRNYPNEARVRATYDLITHILAE	91.32	gnl|BL_ORD_ID|2430|hsp_num:0	2844			438	621	benzylpenicillin
BGC0000243.1|Macrotetrolide_13 # 12111 # 13079 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.723	BGC0000243.1|Macrotetrolide_13 	12111	13079	+	Loose	500	26.5646	APH(6)-Ib	30.85	3002658	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(6)	ATGCACGACGAGACCTCCCTGTGGCGCGAGAGCGGACTGCGCCTGTCCGGATTCGGGCACTACTACCCACGTCTCCAGGTGGAGAACGAGAGCGCCGAGGACCCCGCGGGCAACGCGGTGGACGAGGCCGTCATCGGCCGGCTCGACGTCCGCAGCCGCCATGTGGCGGACGAGGAGGAGACCCCCGCGTACATGGGGGTGCGCGCCGCCCGTGCGGCCATGGAGCAGGCGGGCATCACCGCCGACGAGGTGGACCTGCTGATCCTCAGCAACTGGACGGACCGTCAGTTCGTCCCCGAGTGGGCCCCGCACACCGCGCACCTGCTGGGTGCGGACCGGGCGCTCGCCTTCGACGTGTGCGGCGCCTGCACGGGGTTCGTGCACGGGGTCCAGACGGCGGCGGCGCATCTCGGGACACACGCCACCTGGCGCCACGCGCTGGTCGTCTCCAGCGAGCGGTTCTCGCGCCGGGTGCGCCCGGGCAGCAAGGGCGAGCTGATCGTGGGCGACGCGGCCGGCGCGGCCGTGGTGTCGCGCGGCGCCGGGCCGGGCGCCGGCCTGTGGGACTCGCTGCTGATCAGCGACGGCTCCGGCCGGGAGACGGTCACCGTGTACCCGCCCAACGGATGGATCAGGAGCAGCCGCGAGCTGGTCTCCATCGCCGCCGACTCCCACGCCGATCTGGCCGCCCGGATGCTGGCCCGCTCGGGCACGAAGATGGACGAGATCGACTGGGTGGTGCCGCACCCCGGAACGGGCCAGCTGCACACCGCCGTACGGGAACGTCTCGGCATCCCGGAGGAACGCTTCGTCACCAACTACGAGACCCGGGCGAACACCGGCAGCGCCTCGGTGCCGATCGTGCTCTCCGAGATGGCGCGCGAGGGCCGGCTGAAGGCCGGGGACCTCTGCTACACGCCCACGGTGGGTTCGGGCTGGTACTACGGGGGGCTGCTCTTCCGTGTCTGA	MHDETSLWRESGLRLSGFGHYYPRLQVENESAEDPAGNAVDEAVIGRLDVRSRHVADEEETPAYMGVRAARAAMEQAGITADEVDLLILSNWTDRQFVPEWAPHTAHLLGADRALAFDVCGACTGFVHGVQTAAAHLGTHATWRHALVVSSERFSRRVRPGSKGELIVGDAAGAAVVSRGAGPGAGLWDSLLISDGSGRETVTVYPPNGWIRSSRELVSIAADSHADLAARMLARSGTKMDEIDWVVPHPGTGQLHTAVRERLGIPEERFVTNYETRANTGSASVPIVLSEMAREGRLKAGDLCYTPTVGSGWYYGGLLFRV	MSTSKLVEIPEPLAASYARAFGEEGQAWIAALPALVEELLDRWELTADGASASGEASLVLPVLRTDGTRAVLKLQLPREETSAAITGLRTWNGHGVVRLLDHDPRSSTMLLERLDASRTLASVEDDDAAMGVLAGLLARLVSVPAPRGLRGLGDIAGAMLEEVPRAVAALADPADRRLLNDWASAVAELVGEPGDRMLHWDLHYGNVLAAEREPWLAIDPEPLAGDPGFDLWPALDSRWDDIVAQRDVVRVVRRRFDLLTEVLGLDRARAAGWTYGRLLQNALWDIEDGSAALDPAAVTLAQALRGH	104.89	gnl|BL_ORD_ID|811|hsp_num:0	880			327	606	streptomycin
BGC0000243.1|Macrotetrolide_14 # 13072 # 13983 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.737	BGC0000243.1|Macrotetrolide_14 	13072	13983	+	Loose	600	25.0238	vanS gene in vanP cluster	39.47	3007192	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	GTGTCTGAGCAGTCATCAACAGCGTTGCCGCGCACGAGTGTTCGCGGCACCGCCCTGGTCACCGGCGGCAGCCGGGGACTCGGCGCCGCCATCGCCCGAAAGCTGGCCGCCGTCGGCTGGCACACCGTGATCTGCGGGCGCGACCCGGAGAGCCTGGACGCCGGGGTGAAGGCGGCGGCCGAGGACGGGCTCGTCCTGCACGCCGTGCGGGCGGACGTCACCGACGAGCGGTCGGTGGCCGCCCTCTTCGAGCGGCTGGCCGAGGACGCCCCGCCGCTCGGGCTCTGCGTCAACAACGCGGGGAACAACTTCTCCCGCCGCCTGGTGAGCGTCAAGGAACGGAGCGACGGCCCGCCGCTGCTCTCCCCACACCCGCTGGAGGACTTCGAGCGGGTGGTGACGTCCCTGCTCACCGGCACCTTCCTCGTCGGCCGCCACGCGGCGCAGGCGATGCTGACCGCCGGCACGCCCGGGGCGATCGTCAACATCTCCTCCACGGTCCGGCACGGCGCGTACGGGCAGTCGGCGTACTGCGCGGCCAAGTCCGGGGTGGAGGCGCTGACCCGCACCTGGGCGACCGAGCTGGGCGAGTACGGCATCCGGGTCAGCGCGGTGGCGCCCGGAGTCATTGACGGCGAGGCGCTGCGCCGCCGTTCGGCGGCGAACGAGCGGCACGCGGCCTATATGACCGACCTCCGGCGCCATGTGCCGCTGCGCCGCTGGTGCGACGAGAGGGACGTGGCCGAGGCGGTCGCCTTCGCCGCCGACAACCCCTCGGTGACCGGCACCGTGCTGGAGGTCGACGCGGGCGGACTGCCCGCCCGCGTCCTGCCCCCGGCCGACCGGACCACCGCACCACGTACGACAGCCGCGACGGCGGACCTCCCCGAGAAAGCGGAGAAAACAGCATGA	MSEQSSTALPRTSVRGTALVTGGSRGLGAAIARKLAAVGWHTVICGRDPESLDAGVKAAAEDGLVLHAVRADVTDERSVAALFERLAEDAPPLGLCVNNAGNNFSRRLVSVKERSDGPPLLSPHPLEDFERVVTSLLTGTFLVGRHAAQAMLTAGTPGAIVNISSTVRHGAYGQSAYCAAKSGVEALTRTWATELGEYGIRVSAVAPGVIDGEALRRRSAANERHAAYMTDLRRHVPLRRWCDERDVAEAVAFAADNPSVTGTVLEVDAGGLPARVLPPADRTTAPRTTAATADLPEKAEKTA	MNKRLKKSISRYFFIRFLQGLCCMSFFLVFALGISYLWCSERVWYEGEVSYFIVHILHEYWYVLFLGLMIIGCIVIAMINIRCIAQGISDIMQAVRDVNEENEVQIELPDYLADAQAQLTDIKNHVEWNKKTAQEAVQRKNDLIMYLAHDLKTPLTSTIGYLTLLHDEKEISKEVRDKYMGIALKKSLRLEELLNEFFEIARFNFSTMVLEKGNVNMSVMVEQLLYEFKPLFDKKGLTYTIDLEKDVNVYCDVEKMERVFDNLLKNIVNYSYENTEIAITLKANGEQGMLFVIRNHGKTIPKEKCERIFEQFYRLDGSRGTKTGGSGLGLAVVKEIVELHEGTVTCESENEEICFRITI	84.40	gnl|BL_ORD_ID|4822|hsp_num:0	5808			954	1059	vancomycin; teicoplanin
BGC0000243.1|Macrotetrolide_15 # 13980 # 14804 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.726	BGC0000243.1|Macrotetrolide_15 	13980	14804	+	Loose	450	55.8398	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	24.07	3004045	protein variant model	F203L	n/a	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	ATGACCAGCGGCTTCGCACCCACCCTGCTCCAGGGCAGGACCACCTTTCTGACCGGCGCCAGCAGCGGGATCGGCGCGGTCCTGGCGACGATGCTCGCCGCCCACGGCTCCAGCGTGGCGCTCATGGCCCGCAGCGAGAAGGAGCTCCGGCTGCTGGCCGAGCGGATCGAGGCGGACGGCGGGCGGGCGGTGGCGGTCCCCGGTGACCTCACCGACGGCGACAGTGTGCGCGCCGCCGTCCGCGAGGCCGAGGAACAGCTCGGCCCGATCGACCGGCTGGTGCACTGCGCGGGCGAGGCCCGCAACCAGGCGTTCCTGTGCGACCAGGACGAGGAGCAGTGGACGGCCACCCTCGACATCAACCTGCTGGGGGCCTTCCGGGTCGCCCGTGCGGTGGTGCCGGGGATGATGGAGCGCCGCGAGGGCAACATCGTGATGGTCTCCTCCATCGCCGGGAAGCGCGGGCTGCCCGCCAACACCTCGTACTGCGCCTCGAAGTTCGGGCTCAACGGCATGACGCAGGCGCTCGCCTCCGAGCTGGGCTCCTTCGGCGTGCGGGTCAACGCGGTCTGCCCCGGGCTCACCGACAGCCCCGCCGCCACGGACGGCGGACGGTACGGCGACGCCTTCATGGCCGCCATCGCCAAGCACCACGGCCCCCCGGACCTGACCTGGGAGCGGTACCTCAGGCGCGCGGTCAACAGCACCATCCTGCGGCGCCTGGTGCGCCCCGAGGAGATCGCCGCCCAGGTCCTGTTCCTGCTCTCCGACCTCTCCGGCGGGATGACCGGACAGGCCGTCAACGTGGACGCGGGGGCTCTGTGA	MTSGFAPTLLQGRTTFLTGASSGIGAVLATMLAAHGSSVALMARSEKELRLLAERIEADGGRAVAVPGDLTDGDSVRAAVREAEEQLGPIDRLVHCAGEARNQAFLCDQDEEQWTATLDINLLGAFRVARAVVPGMMERREGNIVMVSSIAGKRGLPANTSYCASKFGLNGMTQALASELGSFGVRVNAVCPGLTDSPAATDGGRYGDAFMAAIAKHHGPPDLTWERYLRRAVNSTILRRLVRPEEIAAQVLFLLSDLSGGMTGQAVNVDAGAL	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	104.58	gnl|BL_ORD_ID|4712|hsp_num:0	2666			6	750	triclosan
BGC0000243.1|Macrotetrolide_10 # 7941 # 9233 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.732	BGC0000243.1|Macrotetrolide_10 	7941	9233	+	Loose	750	147.517	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	30.64	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGGACAGCAGCCGATCCCCTTCCCCGGACCCCTCCGATCCCATCGTGCTGACCGGCATCGGATGCGTGCTGCCCGGCACCCCCGATGTCCATTCCTTCTGGAGCCATGTCTCCACCGGTACCTCACAGGTGAGCCGGCTGGAGTCGCCGGCGTTCGCCGCCGCCGGGCTGCCGGTCCACGCGGCCGCGCAGCTCGGCGCCTTCGACACCGGGGCCCGGCTGCCGGACCTCCTGCCGGCGCACGCCGCGAAGTACAACCGCGACATCCTGGCGACCATGGCCGCCGTGGGCGACGCCCTGGAGGACGCCGGGATCGCCCGGGGCCAGATCGCCCCGGAGCGCATGAGCATCGTCCAGTCCTCGTCCCGCGGCCCGCTGTCCTGGTGGGCCGAGACCATCGCGGCGGACCCGGAGCAGAACCCGTACGGGGGCAGGGCGACGGCCATGTTCCGCGGTCTGGCCGGCTGTCCGGCCACCCTCGCCGCCATCGGCGTCGGCGCGAAGGGCCTGGTCACCACGGTCAGCAGTGCCTGTGTCGGTGGCCACCACGCGATCGGTCTCGCTCTGCGCGAGCTGCGTTCGGGCAGTGCCGACGTGGTCCTCGCCGGTGGGCACGAGTTCCCGATCGCCCCCGAGGTCGCCCGCTGCTACCTGGCGCTCGGGGACGGGGTGCTCTCGCCCGAGAGCGACGCCCCCGCCACCGCCGTACGCCCCTACGACCGGGACCGGCGCGGATTCGCCCTGGGCGAGGGCGCCATGACGCTCTGCCTGGAGCGCGAGTCGTCGGCCCGGGCGCGCGGCGCCCGGATCTACGCACGGATCCTGGGCCACCGCGCCCTCAACGAGGCCAACCACGCCACCAGCATGGACCTGGTCGGGGACGTCACCGCCTCGGTCGTCGCGGGCGTGCTCGACGACGCCGGGCGCAAGCCGGAGGAGATCGGCTACGTCTGCGGCCACGGCACCGCCACCCGGTACAACGACATCGCCGAGAGCCGGGCCCTGCGCCGCCTGCTGCCGCGCCACGACGACGCGGACCTGCCGCCGCACGGCTCCAACAAACCCATCTACGGCCACACGTTCGGCATGGCCGGGATCATCAACGTCGCCGCCACCTCGCTGATGCTCCATCACCAGCGGCTGGCCCCGACCGCCAACCACGTCACGCCGGACCCCGAGTGCGACTACGACCACGTCGCCGGGGGGCCGCGCGACACCGAGATCGACCTCGCGGTCTCGCTGTCCTTCGCCTTCGGCTCGCAGACCTCCGTCATGGCCCTGGAGCACGCATGA	MDSSRSPSPDPSDPIVLTGIGCVLPGTPDVHSFWSHVSTGTSQVSRLESPAFAAAGLPVHAAAQLGAFDTGARLPDLLPAHAAKYNRDILATMAAVGDALEDAGIARGQIAPERMSIVQSSSRGPLSWWAETIAADPEQNPYGGRATAMFRGLAGCPATLAAIGVGAKGLVTTVSSACVGGHHAIGLALRELRSGSADVVLAGGHEFPIAPEVARCYLALGDGVLSPESDAPATAVRPYDRDRRGFALGEGAMTLCLERESSARARGARIYARILGHRALNEANHATSMDLVGDVTASVVAGVLDDAGRKPEEIGYVCGHGTATRYNDIAESRALRRLLPRHDDADLPPHGSNKPIYGHTFGMAGIINVAATSLMLHHQRLAPTANHVTPDPECDYDHVAGGPRDTEIDLAVSLSFAFGSQTSVMALEHA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	103.37	gnl|BL_ORD_ID|1968|hsp_num:0	1943			75	1239	isoniazid
